In patients with diabetes, increased LOX activity has been reported in skin biopsies and vitreous samples from the eye [31,32,33] as evidenced from increased LOX-mediated collagen crosslinks and early glycation products, glucitolyllysine and glucitolylhydroxylysine, which are indirect measures of LOX activity [32,33]. This evidence concerns the gene LOX and diabetes mellitus.